CVS Health stock analysis
CVS Health (CVS) Stock Price & Analysis
CVS Stock Chart & Stats
- Day’s Range
- N/A
- 52-Week Range
- N/A
- Previous Close
- N/A
- Volume
- N/A
- Average Volume (3M)
- N/A
- Market Cap
- CHF 94.00B
- Enterprise Value
- CHF 171.23B
- Total Cash (Recent Filing)
- CHF 14.89B
- Total Debt (Recent Filing)
- CHF 75.30B
- Price to Earnings (P/E)
- 10.3
- Beta
- N/A
- Next Earnings
- Feb 17, 2027 (Est.)
- EPS Estimate
- 0.93
- Next Dividend Ex-Date
- N/A
- Dividend Yield
- N/A
Bulls Say, Bears Say
Bulls Say
Strong Cash Generation
Robust operating and free cash flow provides internal funding for debt reduction, investment, dividends, and potential repurchases. The raised cash-flow outlook also indicates improving earnings quality and gives CVS greater flexibility to manage healthcare volatility over the next several quarters.
Integrated Healthcare Platform
The combination of insurance, pharmacy benefits, retail pharmacies, and care delivery creates multiple customer touch points and supports coordinated utilization management. This structure can improve engagement, purchasing scale, and affordability while giving CVS a durable position across healthcare services.
Improving Medicare Economics
Medicare margin recovery can materially strengthen the Health Care Benefits segment because disciplined pricing and repricing are improving the economics of a large membership base. Continued margin improvement would make earnings less dependent on temporary cost actions and support more durable profitability.
Bears Say
Thin Profit Margins
Low net and operating margins leave limited room for reimbursement pressure, medical-cost inflation, or unfavorable business mix before earnings are affected. Although revenue and net income improved, profitability remains materially below prior stronger periods, making sustained margin recovery essential.
Meaningful Leverage
CVS has improved leverage, but its sizable debt load still consumes financial capacity and can constrain capital allocation. Maintaining strong cash generation is important because weaker operating performance could reduce flexibility for investment, shareholder returns, or balance-sheet improvement.
2027 Operating Headwinds
Several structural pressures could weigh on near-term earnings even as management describes 2027 as a trough year. Lower membership and 340B revenue can reduce Health Services scale, while elevated medical costs and separation expenses may delay broader margin normalization.
CVS Health News
CVS FAQ
What is CVS Health’s market cap?
When is CVS Health’s upcoming earnings report date?
How were CVS Health’s earnings last quarter?
Is CVS Health overvalued?
Does CVS Health pay dividends?
What is CVS Health’s EPS estimate?
What happened to CVS Health’s price movement after its last earnings report?
Which hedge fund is a major shareholder of CVS Health?
What is the TipRanks Smart Score and how is it calculated?
CVS Health Stock Smart Score
Company Description
CVS Health
CVS Health Corp. is a health solutions company, which engages in the provision of healthcare services. It operates through the following segments: Health Care Benefits, Health Services, Pharmacy and Consumer Wellness, and Corporate and Other. The Health Care Benefits segment operates as a health care benefits provider. The Health Services segment offers a full range of PBM solutions, delivers health care services in its medical clinics, virtually, and in the home. The Pharmacy & Consumer Wellness segment dispenses prescriptions in its retail pharmacies and through its infusion operations. The Corporate and Other Segment is involved in management and administrative expenses. The company was founded by Stanley P. Goldstein and Ralph Hoagland in 1963 and is headquartered in Woonsocket, RI.
- Sector
- Healthcare
- Industry
- Medical - Healthcare Plans
- CEO
- J. David Joyner
- Employees
- 259,500
- Website
- www.cvshealth.com
- Address
- One CVS Drive, Woonsocket, RI, 02895, US
CVS Health (CVS) Earnings & Revenues
CVS Company Deck
CVS Earnings Call
Earnings Call SentimentPositive
The call was strongly positive. CVS Health reported broad-based third-quarter earnings growth, raised 2026 revenue, adjusted EPS, operating income and cash flow guidance, achieved its leverage goal ahead of schedule and expects to resume share repurchases. Management also presented improving Medicare performance, continued pharmacy growth and a favorable longer-term outlook. The principal challenges were elevated medical cost trends, expected 2027 pressure from 340B and lower Caremark membership, and costs associated with the planned separation, but management characterized these items as manageable and described 2027 as a trough year for Health Services.
View all CH:CVS earnings summariesCVS Net sales Breakdown
- 46.57% Health Services
- 35.05% Health Care Benefits
- 33.40% Pharmacy & Consumer Wellness
- 0.12% Corporate/ Other
